Financhill
Back

Vaxcyte Stock Predictions

Vaxcyte Stock Forecast

  • Over the next 52 weeks, Vaxcyte has on average historically risen by 18.5% based on the past 5 years of stock performance.
  • Vaxcyte has risen higher in 3 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
  • Is Vaxcyte Stock Undervalued?
    The current Vaxcyte [PCVX] share price is $36.24. The Score for PCVX is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
  • PCVX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Vaxcyte Stock Go Up Next Year?

  • Over the next 52 weeks, Vaxcyte has on average historically risen by 18.5% based on the past 5 years of stock performance.

Vaxcyte Stock Rating

Buy
52
Vaxcyte (PCVX) is a Buy

Is Vaxcyte overpriced?

  • Vaxcyte has risen higher in 3 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%

Vaxcyte Stock Price History

Is PCVX stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PCVX is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
vaxcyte.com

52-Week Data

52-Week High:
121.06
52-Week Low:
27.66

Prediction Charts

Market Cap:
4.7B
Price in USD:
36.24
Volume:
1.3M
Beta:
1.21

Technical Analysis

SMA50:
33.43
SMA100:
45.76
SMA200:
71.51
52-Wk Change:
-55.25%

Stock Predictions

  • Is Vaxcyte stock public?
    Yes, Vaxcyte is a publicly traded company.
  • What is the Vaxcyte stock quote today?
    The Vaxcyte stock price is 36.24 USD today.
  • How to buy Vaxcyte stock online?
    You can buy Vaxcyte shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jun-20 33.58 32.87 33.71 32.54
Jun-23 32.64 33.25 33.61 32.43
Jun-24 34.60 34.09 34.60 33.40
Jun-25 33.97 33.09 34.12 33.05
Jun-26 33.48 32.88 33.48 32.06
Jun-27 32.88 32.58 33.81 32.31
Jun-30 32.94 32.51 33.62 32.49
Jul-1 32.28 32.94 34.63 32.00
Jul-2 33.20 33.27 34.42 33.10
Jul-3 33.42 33.25 34.30 32.87
Jul-7 33.12 32.00 33.17 31.79
Jul-8 32.20 33.46 33.91 32.08
Jul-9 33.75 35.78 36.07 33.74
Jul-10 35.96 36.24 36.89 35.13

Vaxcyte Earnings

Vaxcyte Earnings Report: Per Share Vaxcyte Earnings Q1 Q2 Q3 and Q4 last year and next year.

Vaxcyte Forecast Revenue Growth

Vaxcyte Stock Analysis: Historical quarterly revenues per share for Vaxcyte and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.21 per share, a decrease next quarter of $0.14 per share, a decrease this year of $0.77 per share, and a decrease next year of $0.52 per share.

* Vaxcyte stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.